Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03158207 · ClinicalTrials.gov registry record · NA

Safety and Efficacy of a Novel Facemask for Positive Pressure Ventilation

A NA study of Anesthesia Induction Ventilation, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
152
Enrollment target
1
Study location

NCT03158207: Completed NA study of Anesthesia Induction Ventilation, sponsored by Medical University of South Carolina.

NCT03158207 is a NA study of Anesthesia Induction Ventilation that has completed, run by Medical University of South Carolina. The registered enrollment target is 152 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03158207, a NA study of Anesthesia Induction Ventilation, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
152 participants
Enrollment target
1
Study location

Study Summary

Positive pressure ventilation can be life saving for patients who are hypoxic, hypercapneic or apneic. Manual ventilation with a facemask is a skill that is routinely required for emergency medical technicians, respiratory therapists, nurses and physicians. Although mask ventilation skills are routinely taught, even the most skilled and experienced anesthesiologists struggle to effectively mask-ventilate. The effective use of a standard mask requires the simultaneous establishment of a seal between the mask and face and the lifting of the jaw. The preferred grip is referred to as the C\&E technique. The C\&E technique requires the index finger and thumb to form a "C" and push down on the mask to establish a seal between the mask and face. The lateral three fingers form the "E" and wrap under the jaw to provide lift. The grip required to establish the seal and jaw lift simultaneously is awkward and difficult to teach. The basic design of the standard facemask has not changed in approximately 100 years. This study will evaluate a new mask design, Warters Mask, is based on a novel design that allows a far more ergonomic grip. The C\&E technique is replaced by a more natural grip. With the Warters Mask, downward pressure with the palm of the hand centered on the mask provides the seal between the face and the mask. The other four fingers align under the jaw to provide lift.

Primary Outcome

The primary outcome will be the Warters Scale score for each mask, compared between patients.

Interventions

  • DEVICE Waters Mask
  • OTHER Standard Mask

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 152 participants
Start Date 2015-09-15
Est. Completion 2016-12-15
Phase NA

What the finished NCT03158207 record still lists

NCT03158207 is an interventional study that assigns participants to a tested intervention. The registered 152 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Anesthesia Induction Ventilation appearing as the primary indexed condition, and to 2 interventions - of which Waters Mask is the first listed.

NCT03158207 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT03158207 about?

NCT03158207 is a clinical study titled "Safety and Efficacy of a Novel Facemask for Positive Pressure Ventilation". Positive pressure ventilation can be life saving for patients who are hypoxic, hypercapneic or apneic. Manual ventilation with a facemask is a skill that is routinely required for emergency medical technicians, respiratory therapists, nurses and physicians. Although mask ventilation skills are routi...

What is the current status of trial NCT03158207?

This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2015-09-15. Estimated completion is 2016-12-15.

What conditions does trial NCT03158207 study?

This clinical trial studies the following conditions: Anesthesia Induction Ventilation.

What interventions are being tested in trial NCT03158207?

The interventions under investigation include: Waters Mask (DEVICE), Standard Mask (OTHER).

Who is sponsoring clinical trial NCT03158207?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03158207 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT03158207's enrollment target sits among peer trials

152 658th of 2000 higher than 1,340 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03328078 · 152 participants · Phase 1

    CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • NCT04458532 · 152 participants · NA

    Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast Cancer

  • NCT04858334 · 152 participants · Phase 2

    APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation

  • NCT04993859 · 152 participants

    Impact of Chemotherapy on Urinary Biomarkers and Non-Invasive Urodynamics in Children

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03158207, the US trial registry maintained by the National Library of Medicine. NCT03158207 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.